Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
14 September 2021 | Story Dr Jan du Plessis and Dr Mampoi Jonas

Opinion article by Dr Jan du Plessis, Head of the Paediatric Oncology Unit, and Dr Mampoi Jonas, senior lecturer in the Paediatric Oncology, University of the Free State 


For many years childhood cancer has remained a taboo subject in our communities, mainly because too little was or is known about it. Many have known or come across an adult with cancer but for a child to be diagnosed with cancer is totally unheard of. No parent wants to hear the news that their ‘heartbeat in human form’ has fallen ill. One moment they are OK, the next, waves of emotions flood the parents. Mixed in all this are feelings of guilt, anxiety, uncertainty, constant wondering if they could have done anything differently. Most importantly the question, often unuttered remains “Is my child dying/ how much time do I have”.

Most young cancer patients live in developing countries

Childhood cancer is rare and involves only 1% of all cancers. It is reported that globally approximately 70% of all childhood cancer cases occur in low- and middle-income countries. If diagnosed early, approximately 70-80% of childhood cancers are curable in developed countries. Unfortunately, most children with cancer live in developing countries with limited resources and the cure rate does not reflect the same success. The low survival rates can be attributed to poor diagnosis coupled with too few specially trained doctors and nurses and the misbelief that child cancer is too difficult to cure. However, even in resource-poor environments at least 50% of childhood cancers can be cured.

Numerically, childhood cancer is not a significant cause of death in sub-Saharan African countries, which leaves childhood cancer less of a priority. In Africa, the most common paediatric health problems are malnutrition, infectious diseases such as HIV and tuberculosis. Whereas in Western countries, after accidents, cancer is the second leading cause of death in children and is a burden to the health system.

A study done by Stones et al in 2014 published the survival rates for children with cancer in South Africa at two different Units (Universitas and Tygerberg Hospitals) to be around 52%. The conclusion was that the children present late and with advanced-stage disease, which obviously affects their outcome. They also concluded that strategies to improve awareness of childhood cancer should be improved. Identifying early warning signs of childhood cancer is critical for parents and healthcare workers to ensure early diagnosis and improved cure rates. We often refer to these as red flag signs that should raise suspicion of the possibility of cancer as a diagnosis for the presenting patient.

Almost 85% of childhood cancers will present with the red flag signs, which could suggest the possibility of a childhood cancer, namely:
1. Pallor and purpura (bruising)
2. Bone and joint pain
3. Lymphadenopathy
4. Unexplained masses on any body part
5. Unexplained neurological signs
6. Changes in the orbit or eye
7. Persistent unexplained fever and weight loss

The most common cancer in children is leukaemia (blood cancer). Brain tumours are the most common non-haematological cancers, followed by nephroblastomas (kidney cancers) and neuroblastomas (sympathetic chain cells, the adrenal glands the most common site of origin).

We honour the children currently battling cancer and their families 

Once there is clinical suspicion of cancer, the child should be investigated or referred for the relevant investigations to be conducted to get to the right diagnosis. Treatment for childhood cancer includes chemotherapy, surgery or radiotherapy. These may be given separately or in combination depending on the diagnosis. Many models of care exist, but regardless of the outcome, children and families who receive compassionate, holistic care of symptomatology and address their non-physical needs are able to face their illness with dignity and energy.  

Childhood Cancer should not remain a taboo subject in South Africa and should be a topic of conversation more often so that people can be educated regarding the early warning signs and become more aware of its occurrence amongst children. Get the word out that a cure is possible. This month, which is known as Childhood Cancer Awareness Month, and throughout the year, we honour the children currently battling cancer, the families who love them, the clinicians and other caregivers treating them, the survivors of childhood cancer and the children who lost their lives to childhood cancer. 

Authors

Dr Jan Du Plessis for web 
Dr Jan du Plessis is the Head of the Paediatric  Oncology Unit in the Faculty of Health Sciences at
the University of the Free State (UFS).  


DrJonas for web
Dr Mampoi Jonas is a senior lecturer in the Paediatric Oncology, University of the Free State (UFS).

News Archive

Maize breeder rewarded for his research to enhance food security in Africa
2016-08-26

Description: Maize breeder rewarded  Tags: Maize breeder rewarded

Prof Maryke Labuschagne from the UFS Department
of Plant Sciences, Berhanu Tadesse Ertiro, a
postgraduate student in Plant breeding at the UFS,
and Dr Peg Redinbaugh of the US Department of
Agriculture in Wooster, Ohio.
Photo: Supplied

Ethiopia is one of the African countries, deeply affected by food insecurity. Berhanu Tadesse Ertiro, a citizen from Ethiopia started his career - after graduating with his undergraduate degree in 2003 - as a junior maize breeder. Today he is pursuing his doctorate degree in Plant Breeding at the University of the Free State (UFS).

His research had made some great strides in contributing to food security in Africa. He recently received a fellowship from the prestigious Norman E. Borlaug Leadership Enhancement in Agriculture Program (Borlaug LEAP).

This fellowship is only awarded to students whose research has relevance to the national development of the student’s home country or region. The aim of these fellowships are to enhance the quality of thesis research of graduate students from developing countries who show strong promise as leaders in the field of agriculture and related disciplines.

Low soil fertility a major maize production constraint
Berhanu is also a visiting student at the International Maize and Wheat Improvement Center (CIMMYT) in Kenya, where he is running field experiments for his PhD thesis dissertation. His research focuses on Nitrogen Use Efficiency (NUE) and Maize Lethal Necrosis (MLN) disease tolerance. Low soil fertility and MLN are among the major maize production constraints in eastern and southern Africa, where maize is staple food.

Such hybrids have the potential to contribute greatly
towards food security among farmers and their
families through increased productivity.

The use of new tools could increase breeding efficiency and reduce the time needed for the release of new stress tolerant hybrids. Such hybrids have the potential to contribute greatly towards food security among farmers and their families through increased productivity. Berhanu is looking at the feasibility of genome wide selection for improvement of NUE in tropical maize.

Fellowship includes mentorship and supervision across borders
The programme supports engaging a mentor at a United States university and Consortium of International Agricultural Research Centers (CGIAR). During his fellowship, he will be supervised and mentored by Prof Maryke Labuschagne of the UFS, Prof Rex Bernando, a professor of Corn Breeding and Genetics at the University of Minnesota and Dr Biswanath Das of CIMMYT, Kenya.

As a LEAP fellow, Berhanu was invited to attend the 30th Annual World Food Prize events to take place in October 2016, in Des Moines, Iowa. The week will include his attendance at the Board for International Food and Agricultural Development meeting, participation at side-events at the Borlaug Dialogue International Symposium and the World Food Prize.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept